native glp-1 GLP-1-based therapies for diabetes, obesity and beyond Glucagon-like peptide-1 analogues: An overview

Jensen MD, Ryan DH, Apovian CM, et al

Studies have shown that GLP-1 injections also lead to lower food intake by reducing hunger and cravings

The unexpected finding that exendin-4 has neuroprotective effects in animal models of various neurodegenerative diseases opens the door to testing this drug as a treatment for a number of devastating human diseases, such as Alzheimers. I think the fact that we have been able to take this substance found in nature and consider applying it in such incredibly diverse waysto treat diabetes, to possibly treat neurological diseaseadds to the growing body of support for a link between the endocrine and nervous systems, adds Dr

The dose is increased by 0.6 milligrams each week until the maintenance dose of 3.0 milligrams is reached

Membership Made for You At Ivm Health, we recognize that each persons health journey is unique